Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
05/2003
05/06/2003CA2189698C Substituted 1,2,3-triazol-3-ones
05/02/2003EP1306376A1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
05/02/2003EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/02/2003EP1306371A1 Cyclic imines
05/02/2003EP1305309A1 Lactam inhibitors of factor xa which are useful for the treatment of thrombosis
05/02/2003EP1305308A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
05/02/2003EP1305307A1 Indole derivatives useful for the treatment of cns disorders
05/02/2003EP1305305A1 Hyperpolarizable organic chromophores
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305288A1 Potassium channel inhibitors
05/02/2003EP1305286A2 Cyclopentanoindoles, compositions containing such compounds and methods of treatment
05/02/2003EP1305028A2 Antimicrobial biaryl compounds
05/02/2003EP1305026A2 Barbituric acid analogs as therapeutic agents
05/02/2003EP1105381B1 Dibenzothiophene compounds and methods of use thereof
05/02/2003EP1086103B1 Pyrido 2,3-b]indolizine derivatives and aza analogues thereof; crf 1 specific ligands
05/02/2003EP1045846B1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
05/02/2003EP1037886B1 Triazine angiogenesis inhibitors
05/02/2003EP0810226B1 Pyrazole derivatives
05/02/2003EP0772593B1 Thiopyridyl compounds for controlling helicobacter bacteria
05/02/2003EP0738150B1 Bicyclic fibrinogen antagonists
05/02/2003EP0724387B1 Angiotension ii receptor antagonists for the treatment of chronic anti-inflammatory diseases
05/01/2003WO2003035714A1 Triarylamine containing monomers for optoelectronic devices
05/01/2003WO2003035647A1 Alkyl ether derivatives or salts thereof
05/01/2003WO2003035646A2 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
05/01/2003WO2003035644A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003WO2003035639A1 Pyrimidine compound and medicinal composition thereof
05/01/2003WO2003035638A1 4-imidazolin-2-one compounds
05/01/2003WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity
05/01/2003WO2003035624A1 Quinoline compound
05/01/2003WO2003035076A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
05/01/2003WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
05/01/2003WO2003035057A1 Inhibitors of dipeptidyl peptidase iv
05/01/2003WO2003005824A3 Substituted 3-heteroaryl (amino-or-oxy)-pyrrolidin-2-ones, method for the production thereof and use thereof as herbicides or as plant growth regulators
05/01/2003WO2002090352A3 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
05/01/2003WO2002079186A3 Aminopiperidine derivatives as modulators of chemokine receptor activity
05/01/2003WO2002038553A3 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
05/01/2003US20030083518 Substituted alcohols useful in treatment of Alzheimer's disease
05/01/2003US20030083362 Synthesis and antimicrobial activity of novel dicationic"reversed amidines"
05/01/2003US20030083361 Naphtho(1,2-d)imidazole derivatives; treating thrombocytopenia
05/01/2003US20030083347 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
05/01/2003US20030083345 Method of treatment and/or prevention of brain, spinal or nerve injury
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment
05/01/2003US20030083268 Isoquinoline compounds having antiinfective activity
05/01/2003US20030080323 Novel methine compound, material for organic luminescence element, and organic luminescence element using the same
05/01/2003CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003CA2464981A1 Quinoline compound
05/01/2003CA2464254A1 Inhibitors of post-proline cleaving proteases
05/01/2003CA2463975A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
04/2003
04/30/2003CN1414953A Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and 5-hydroxytryptamine
04/30/2003CN1414952A Heterocyclic compounds having sulfonic acid
04/30/2003CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists
04/29/2003US6555690 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
04/29/2003US6555663 Prodrugs for selective drug delivery
04/29/2003US6555570 Growth hormone secretagogous with improved bioavailability
04/29/2003US6555555 Fused thiophone derivatives and drugs containing the same as the active ingredient
04/29/2003US6555542 Sulfonamide lactam inhibitors of FXa and method
04/29/2003US6555537 Piperazine derivatives and their use as anti-inflammatory agents
04/29/2003US6555533 Specific antitumor activity against breast, colon, lung, prostate cancers and melanomas
04/29/2003US6555339 Altering human G protein-coupled receptors (GPCRs) by point mutation; use in drug screening
04/29/2003CA2134347C Thiazole or imidazole derivatives as maillard reaction inhibitors
04/24/2003WO2003033493A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ
04/24/2003WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
04/24/2003WO2003033472A1 Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors
04/24/2003WO2003033470A1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
04/24/2003WO2003032981A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
04/24/2003WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032910A2 Carbinols for the treatment of neuropathic dysfunction
04/24/2003WO2003000679A3 Herbicidal substituted pyridines, method for producing the same and their use as herbicidal agents and plant growth regulators
04/24/2003WO2002100437A3 Ophthalmic compositions comprising hyaluronic acid
04/24/2003WO2002068406A3 Substituted amine derivatives and their use for the treatment of angiogenesis
04/24/2003WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/24/2003WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003US20030078441 Photochromic bis-naphthopyran compounds and methods for their manufacture
04/24/2003US20030078440 O- or S- substituted tetrahydronaphthalene derivatives useful as regulators of cell proliferation and differentiation, useful for treating skin-related diseases
04/24/2003US20030078434 An aromatic sulfonamide compound for treating glomerulonephritis and diabetic nephropathy, having a superior antiproteinuric effect and superior inhibitory activity for type IV collagenase
04/24/2003US20030078431 Biheterocyclic compounds having high anticoagulant activity, used as inhibitors of factor Xa
04/24/2003US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
04/24/2003US20030078418 Useful potentiators of beta -lactam antibiotics; therapy
04/24/2003US20030078286 For therapy of central nervous system disorders such as anxiety, depression, motor disorders
04/24/2003US20030078276 Matrix metalloproteinase inhibitors
04/24/2003US20030078275 For therapy of cancer, diabetes and Alzheimer's disease
04/24/2003US20030078271 Pyrimidine and indolone derivatives
04/24/2003US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
04/24/2003US20030078265 Inhibitors of nitric oxide synthase (nos)
04/24/2003US20030078261 Prostaglandin agonists
04/24/2003US20030078260 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
04/24/2003US20030078258 Adrenergic blocking agents
04/24/2003US20030078253 Matrix metalloprotease inhibitors
04/24/2003US20030078236 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
04/24/2003US20030078166 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003CA2463518A1 Carbinols for the treatment of neuropathic dysfunction
04/24/2003CA2463469A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
04/23/2003EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
04/23/2003EP1303641A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
04/23/2003EP1303509A1 Beta3 adrenergic agonists
04/23/2003EP1303508A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents
04/23/2003EP1303507A1 Pyrimidine derivatives
1 ... 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 ... 523